251 related articles for article (PubMed ID: 12590402)
1. Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects.
Sennef C; Timmer CJ; Sitsen JM
Hum Psychopharmacol; 2003 Mar; 18(2):91-101. PubMed ID: 12590402
[TBL] [Abstract][Full Text] [Related]
2. Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects.
Spaans E; van den Heuvel MW; Schnabel PG; Peeters PA; Chin-Kon-Sung UG; Colbers EP; Sitsen JM
Eur J Clin Pharmacol; 2002 Sep; 58(6):423-9. PubMed ID: 12242602
[TBL] [Abstract][Full Text] [Related]
3. Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers.
Iwamoto K; Kawamura Y; Takahashi M; Uchiyama Y; Ebe K; Yoshida K; Iidaka T; Noda Y; Ozaki N
Psychiatry Clin Neurosci; 2008 Oct; 62(5):610-6. PubMed ID: 18950383
[TBL] [Abstract][Full Text] [Related]
4. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
[TBL] [Abstract][Full Text] [Related]
5. Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects.
Sitsen JM; Maris FA; Timmer CJ
Eur J Clin Pharmacol; 2000 Aug; 56(5):389-94. PubMed ID: 11009047
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mirtazapine and lithium in healthy male subjects.
Sitsen JM; Voortman G; Timmer CJ
J Psychopharmacol; 2000 Jun; 14(2):172-6. PubMed ID: 10890312
[TBL] [Abstract][Full Text] [Related]
8. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
9. Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor.
Rosenzweig P; Patat A; Zieleniuk I; Cimarosti I; Allain H; Gandon JM
Clin Pharmacol Ther; 1998 Aug; 64(2):211-22. PubMed ID: 9728902
[TBL] [Abstract][Full Text] [Related]
10. Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients.
Veldhuijzen DS; van Wijck AJ; Verster JC; Kenemans JL; Kalkman CJ; Olivier B; Volkerts ER
J Psychopharmacol; 2006 Nov; 20(6):782-8. PubMed ID: 16401650
[TBL] [Abstract][Full Text] [Related]
11. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
Pahwa R; Lyons KE
Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
[TBL] [Abstract][Full Text] [Related]
15. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
Ramaekers JG
J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
Montgomery SA; Reimitz PE; Zivkov M
Int Clin Psychopharmacol; 1998 Mar; 13(2):63-73. PubMed ID: 9669186
[TBL] [Abstract][Full Text] [Related]
19. Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects.
Sitsen J; Maris F; Timmer C
Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):109-21. PubMed ID: 11554425
[TBL] [Abstract][Full Text] [Related]
20. Safety of mirtazapine: a review.
Montgomery SA
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():37-45. PubMed ID: 8930008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
